17 CFR § 201.326 - Evidence: Presentation, rebuttal and cross-examination.
---
identifier: "/us/cfr/t17/s201.326"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "17 CFR § 201.326 - Evidence: Presentation, rebuttal and cross-examination."
title_number: 17
title_name: "Commodity and Securities Exchanges"
section_number: "201.326"
section_name: "Evidence: Presentation, rebuttal and cross-examination."
chapter_name: "SECURITIES AND EXCHANGE COMMISSION"
part_number: "201"
part_name: "RULES OF PRACTICE"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "15 U.S.C. 77s, 77sss, 78w, 78x, 80a-37, and 80b-11; 5 U.S.C. 504(c)(1)."
regulatory_source: "47 FR 610, Jan. 6, 1982, unless otherwise noted."
cfr_part: "201"
---
# 201.326 Evidence: Presentation, rebuttal and cross-examination.
In any proceeding in which a hearing is required to be conducted on the record after opportunity for hearing in accord with 5 U.S.C. 556(a), a party is entitled to present its case or defense by oral or documentary evidence, to submit rebuttal evidence, and to conduct such cross-examination as, in the discretion of the Commission or the hearing officer, may be required for a full and true disclosure of the facts. The scope and form of evidence, rebuttal evidence, if any, and cross-examination, if any, in any other proceeding shall be determined by the Commission or the hearing officer in each proceeding.